Oct. 2 (UPI) --Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Indiana expected to open in late 2027.

Eli Lilly's GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list.Yahoo Finance Senior Health Reporter Anjalee Khemlani ...

(This story was updated to add new information.)Eli Lilly and Co. is investing an additional $4.5 billion into the LEAP Research and Innovation District in Lebanon, bringing the drug company's ...

UPDATE, Sept. 30: In an extended second trailer, Robert Eggers’ Nosferatu teases an entranced Lily Rose-Depp, enamored and enticed by death itself. “I’d never been so happy,” she utters ...

The cause of death for baseball legend Pete Rose has been revealed. Rose, MLB’s all-time hits leader who was banned from baseball in 1989 for gambling on Cincinnati Reds games while he served ...

Correction/clarification: An earlier version of this story incorrectly reported Pete Rose’s Hall of Fame status and mischaracterized players who were part of the Reds’ Big Red Machine.

Pete Rose, one of the most recognizable figures in professional baseball during the 20th century, has died at the age of 83. TMZ shared a confirmation from Rose’s agent, Ryan Fiterman ...

Cincinnati Reds great Pete Rose died at his Las Vegas home Monday because of a serious heart condition, a Nevada coroner said Tuesday. Rose, 83, suffered from hypertensive and atherosclerotic ...

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the company widen its share of the booming weight-loss drug market.

Cincinnati Reds legend Pete Rose died at his Las Vegas home Monday because of a serious heart condition, a Nevada coroner said Tuesday. Rose, 83, suffered from hypertensive and atherosclerotic ...

Pete Rose, Major League Baseball‘s all-time hit king, died on Sept. 30 due to hypertensive and atherosclerotic cardiovascular disease with a significant condition of diabetes mellitus.

Oct 3 (Reuters) - England's National Health Services will offer Eli Lilly's (LLY.N), opens new tab weight-loss drug to nearly a quarter million people as part of a three-year plan, the country's ...